OrbiMed Israel is a private equity general partner firm located in Israel.
OrbiMed Israel, Clarus, and HealthCap, with participation from Pontifax, led a $32m Series A funding for Tisbury Pharmaceuticals.
BiomX, an Israel-based microbiome therapeutics company, raised $24m in a Series A from OrbiMed, and others.
Israel-based Nutrinia, an insulin developer for infants, has raised $30m in Series D funding led by TPG Biotech.
Read more news concerning OrbiMed Israel
A sampling of OrbiMed Israel portfolio companies:
View all of the investments in their portfolio
This firm also pursues other investment strategies:
Registration is fast, free and easy
Already a member?